SYI_METB6
ID SYI_METB6 Reviewed; 1076 AA.
AC A7IAM2;
DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT 11-SEP-2007, sequence version 1.
DT 03-AUG-2022, entry version 87.
DE RecName: Full=Isoleucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02003};
DE EC=6.1.1.5 {ECO:0000255|HAMAP-Rule:MF_02003};
DE AltName: Full=Isoleucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02003};
DE Short=IleRS {ECO:0000255|HAMAP-Rule:MF_02003};
GN Name=ileS {ECO:0000255|HAMAP-Rule:MF_02003}; OrderedLocusNames=Mboo_2269;
OS Methanoregula boonei (strain DSM 21154 / JCM 14090 / 6A8).
OC Archaea; Euryarchaeota; Stenosarchaea group; Methanomicrobia;
OC Methanomicrobiales; Methanoregulaceae; Methanoregula.
OX NCBI_TaxID=456442;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=DSM 21154 / JCM 14090 / 6A8;
RX PubMed=25998264; DOI=10.1099/mic.0.000117;
RA Braeuer S., Cadillo-Quiroz H., Kyrpides N., Woyke T., Goodwin L.,
RA Detter C., Podell S., Yavitt J.B., Zinder S.H.;
RT "Genome of Methanoregula boonei 6A8 reveals adaptations to oligotrophic
RT peatland environments.";
RL Microbiology 161:1572-1581(2015).
CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS
CC can inadvertently accommodate and process structurally similar amino
CC acids such as valine, to avoid such errors it has two additional
CC distinct tRNA(Ile)-dependent editing activities. One activity is
CC designated as 'pretransfer' editing and involves the hydrolysis of
CC activated Val-AMP. The other activity is designated 'posttransfer'
CC editing and involves deacylation of mischarged Val-tRNA(Ile).
CC {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L-
CC isoleucyl-tRNA(Ile); Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666,
CC Rhea:RHEA-COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC ChEBI:CHEBI:58045, ChEBI:CHEBI:78442, ChEBI:CHEBI:78528,
CC ChEBI:CHEBI:456215; EC=6.1.1.5; Evidence={ECO:0000255|HAMAP-
CC Rule:MF_02003};
CC -!- COFACTOR:
CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC Evidence={ECO:0000255|HAMAP-Rule:MF_02003};
CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and
CC one for editing. The misactivated valine is translocated from the
CC active site to the editing site, which sterically excludes the
CC correctly activated isoleucine. The single editing site contains two
CC valyl binding pockets, one specific for each substrate (Val-AMP or Val-
CC tRNA(Ile)). {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC IleS type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02003}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP000780; ABS56783.1; -; Genomic_DNA.
DR RefSeq; WP_012107843.1; NC_009712.1.
DR AlphaFoldDB; A7IAM2; -.
DR SMR; A7IAM2; -.
DR STRING; 456442.Mboo_2269; -.
DR PRIDE; A7IAM2; -.
DR EnsemblBacteria; ABS56783; ABS56783; Mboo_2269.
DR GeneID; 5411001; -.
DR KEGG; mbn:Mboo_2269; -.
DR eggNOG; arCOG00807; Archaea.
DR HOGENOM; CLU_001493_1_1_2; -.
DR OMA; HLGTAWN; -.
DR OrthoDB; 4914at2157; -.
DR Proteomes; UP000002408; Chromosome.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-UniRule.
DR GO; GO:0000049; F:tRNA binding; IEA:InterPro.
DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule.
DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule.
DR CDD; cd07961; Anticodon_Ia_Ile_ABEc; 1.
DR Gene3D; 3.40.50.620; -; 2.
DR Gene3D; 3.90.740.10; -; 1.
DR HAMAP; MF_02003; Ile_tRNA_synth_type2; 1.
DR InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR InterPro; IPR002300; aa-tRNA-synth_Ia.
DR InterPro; IPR033709; Anticodon_Ile_ABEc.
DR InterPro; IPR002301; Ile-tRNA-ligase.
DR InterPro; IPR023586; Ile-tRNA-ligase_type2.
DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR PANTHER; PTHR42780; PTHR42780; 1.
DR Pfam; PF08264; Anticodon_1; 1.
DR Pfam; PF00133; tRNA-synt_1; 1.
DR PRINTS; PR00984; TRNASYNTHILE.
DR SUPFAM; SSF47323; SSF47323; 1.
DR SUPFAM; SSF50677; SSF50677; 1.
DR TIGRFAMs; TIGR00392; ileS; 1.
DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE 3: Inferred from homology;
KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Metal-binding;
KW Nucleotide-binding; Protein biosynthesis; Reference proteome; Zinc.
FT CHAIN 1..1076
FT /note="Isoleucine--tRNA ligase"
FT /id="PRO_1000022151"
FT MOTIF 47..57
FT /note="'HIGH' region"
FT MOTIF 591..595
FT /note="'KMSKS' region"
FT BINDING 594
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_02003"
SQ SEQUENCE 1076 AA; 122648 MW; FD3F722F961446C5 CRC64;
MKEVTANFSA KDIEREVQEY WRTHDTYKAV KEQHSAGRAF FFVDGPPYTT GQIHLGTAWN
KIIKDSILRY HRMNGRNVID RAGYDMHGLP IEVKVEQKLG FASKKDIETF GIEKFINECR
EFAIKNKELM DAQFENLGIW MDFKNAYQTI KPWYVEAAWW TLAKAQEKGM LERGYRVVNW
CPRCETAIAD AEVEYWDETD PSVFVKFPIR GKVSESLVIW TTTPWTLPAN VAVAVGKEFV
YARVHAEKNG REEYLWVAED LVKSVLKKGR YQKFETLETK KGAELIGWEY DSPLMDVVPI
QKEIAHRVVA ADFVAMENTG MVHIAPGHGW DDYVLGTKEK LAIVCPVDGA GKFRPETGIF
AGKFVRDANG EVLDALGERL LATEKITHRY GHCWRCKTPI IFRATSQWFL KASEMRDLML
SEVKKVTWYP EWAGSARFYD WIKEARDWCV SRQRYWGIPI PVWICDKCDK YRVIGTIAEL
EKASGQKVPD PHRPFVDQVT IPCECGGTMK RVGDIFDVWF DSAVASWATV GFPAKTDEFE
KLWPADFITE GQDQTRGWFY SQLGASTIAF GKAPYKSVCM HGFALDAEGR KMSKSLGNVV
APEEVIAKVG VDVLRLYVLS SSAPWDDLKF NWDGIATVNR TMNILWNVYR FPMPYMILDR
FEPEAKSGHW DGSFVRSHIR ELPDEDRWIV SRINTVAGIV DASTKECQLH RATREILNFI
LEDLSRWYVQ LVRPRMWLEG ESEQKIFAYE TIYYVMRRLV DLMAPFAPHI TEEIYSNLRC
KNDPGSVHML DWQACDDALT NRELEHAMEL VRSFDDAVQN ARQAGKRKLR WPVDEVVIVT
AKPEVKDAVA RLNEVCMDRA NARKVTVVIG RWDRIGWHAE PVMKALGKGF GKNSFAVKGL
IEAADGNAIK AAVDAGQKFQ LKIEEGKISK PDDLKIGTDY EQDVVEIGIE HVRFTEKLPT
DIFSAPMEDG TVYVDVALTP DLEAEGYARE IIRRIQEMRR QLDLAVEDFI MVDVAVADKR
ICELVGASWK PGIADEVRAK TLSLHHSAEP AGSSHQLAKD WDVEGIAMTI GISKVA